Childhood cancer cases are increasing across the European Union, with newly released data from the European Cancer Information System (ECIS) showing a clear upward trend in diagnoses.
Each September, Childhood Cancer Awareness Month brings attention to the fight against pediatric cancers. One of the promising projects currently making waves in this field is MONALISA, a Horizon Europe-funded initiative under the EU Cancer Mission.
New UKHSA and NHS England data reveal 18.6% of children have not received their pre-school booster vaccine, a vital vaccine for protecting against serious illnesses.
UCSF researchers report a new spatial repellent that provides up to one year of protection against malaria and other mosquito-borne diseases, marking the first WHO-endorsed vector control tool in over four decades.
A new multi-omics AI model combines cfDNA and cfRNA to predict preterm birth risk with nearly 90% accuracy, offering promising insights for maternal health.
Murdoch Children’s Research Institute launches an international trial of a 21-valent pneumococcal vaccine to protect babies against pneumonia, meningitis, and sepsis.
A new study links excessive screen time in children and teens to higher risks of high blood pressure, cholesterol, and insulin resistance, especially when sleep is limited.
The NHS will offer a long-acting antibody injection to protect thousands of premature and vulnerable babies from respiratory syncytial virus (RSV) starting this autumn.
The NHS will provide a new triple combination therapy to hundreds of children and adults with cystic fibrosis in England, aiming to improve lung function and quality of life for eligible patients.
A first-in-patient trial using AAV-based OTOF gene therapy, led by Karolinska Institutet and Chinese hospitals, restored hearing (improving from 106 dB to 52 dB) in 10 individuals aged 1–24.
